Key Points
- To assess the therapeutic role, clinical outcomes, and safety profile of quinidine for converting atrial fibrillation to sinus rhythm following mitral valvotomy.
- Reviewed clinical experience and published medical literature on the use of quinidine therapy in patients with cardiac disease.
- Evaluated clinical indications and treatment outcomes for rhythm conversion in patients presenting with persistent atrial fibrillation after mitral valve surgery.
- Successful conversion of chronic atrial fibrillation to sinus rhythm yields significant cardiorespiratory improvements that support quinidine use.
- Clinical indications, rhythm maintenance rates, and the incidence of adverse toxic effects from quinidine vary substantially across reported medical series.
Structured PICO
PPopulationPatients with atrial fibrillation after mitral valvotomy
IInterventionQuinidine therapy
This historical text discusses the use of quinidine for converting atrial fibrillation to sinus rhythm, noting varying published indications and toxic effects.